Monopar Therapeutics (MNPR) Q3 2025 Earnings

Aug 12Confirmed
Q3 2024
Q4 2024
Q2 2025
Q3 2025
-1
-0.78
-0.57
-0.35

Details

Expected EPS
-0.458333
Actual EPS
-0.35
Surprise EPS
0.11
Surprise Percent
+23.64%

Description

⁨Monopar Therapeutics⁩ (⁦MNPR⁩) has reported earnings of ⁦-0.35⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts